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Aim: To review the types of nonglaucomatous optic neuropathies seen in Port Harcourt, 
Nigeria.
Materials and methods: Medical case records of all cases of nonglaucomatous optic neu-
ropathy seen in the Eye Clinic of University of Port Harcourt Teaching Hospital, Port Harcourt, 
Nigeria over a 5-year period were reviewed. Relevant data including patient demography, 
presenting visual acuity and intraocular pressure, and fundus findings were extracted. Other 
details included central visual field analysis and color vision results. Cases of glaucomatous 
optic neuropathy were excluded.
Results: Ninety-nine cases of optic neuropathy were seen over this time period. There were 52 
(52.5%) males and 47 females. The mean age of those with optic neuropathy was 40 ± 18.774 
years. Twenty-two patients (22.2%) had bilateral involvement, while the rest were unilateral. 
About 40% of the patients with optic neuropathies had optic atrophy. Nutritional causes 
accounted for 31.3% and optic neuritis 27.3%. Over 60% of the patients presented with visual 
acuities #6/60. Most patients (40%) had cecocentral scotoma.
Conclusion: Nonglaucomatous optic neuropathies resulting in optic atrophy is not uncommon 
in our environment and several factors may be implicated but the actual cause is difficult to 
determine because of late presentation of most patients.
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Introduction
The diagnosis of optic neuropathy is usually made on clinical grounds and sometimes with 
the help of ancillary tests such as visual field analysis and optical coherence tomography. 
Rarely can the etiology of optic neuropathy be made on the basis of a single clinical find-
ing because there is considerable overlap of clinical features between even the relatively 
common optic neuropathies.1,2 It is said that in experienced hands, clinical diagnosis is 
reliable and sufficient, and further investigation is not required.3 The clinical diagnosis of 
optic neuropathies is based on the association of visual loss, altered color vision, visual 
field defect, and relative afferent papillary defect (if the optic neuropathy is unilateral).4 
Pathologic cupping of the optic nerve is most commonly associated with glaucomatous 
optic neuropathy but other types of optic neuropathies have also been reported to cause 
cupping of the optic disk; conditions such as ischemic optic neuropathy,5 intracranial 
tumors,6 and optic neuritis.7 Clinically, clues such as optic nerve head pallor can be useful 
in distinguishing glaucomatous from nonglaucomatous optic nerve head cupping.8
The onset of optic neuropathy is not always clear. Inflammatory optic neuropathy 
tends to have a subacute onset over a number of days, frequently accompanied by Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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periocular pain exacerbated by eye movements.9 The almost 
complete recovery of vision over the next few weeks is 
sufficiently characteristic of the vast majority of cases of 
demyelinating optic neuropathy to allow a clinical diag-
nosis, without the need for confirmatory investigation as 
long as there are no atypical features.10,11 Compressive optic 
neuropathy usually causes gradually progressive visual loss, 
although vascular lesions may cause abrupt visual decline 
occasionally, followed by some recovery. Nutritional or toxic 
optic neuropathy results in subacute or chronic symmetrical 
bilateral visual loss. Visual loss due to congenital anomalies 
rarely changes over time.
The ability to differentiate glaucomatous from nonglau-
comatous cupping is usually difficult even with experience, 
however, evaluation of parapapillary chorioretinal atrophy has 
been found to be useful in differentiating both types of optic 
neuropathy.12 Some researchers in the US13 analyzed four 
optic disk features in order to distinguish nonglaucomatous 
from glaucomatous optic neuropathy and found neuroretinal 
rim pallor to be 94% specific for nonglaucomatous atrophy, 
while focal or diffuse obliteration of the neuroretinal rim 
was 87% specific for glaucoma. These two signs were said 
to be the most useful in making the distinction between 
glaucomatous and nonglaucomatous atrophy. Thinning of 
the rim was, however, more common in glaucomatous atro-
phy and laminar dots were said to be present in both types 
of excavation.13 Also, glaucomatous optic neuropathy is not 
symptomatic until late in the disease course such that it is 
usually identified incidentally or by screening.14
The anterior visual pathway is susceptible to damage 
from toxins or nutritional deficiencies. This causes a type of 
optic neuropathy referred to as tobacco–alcohol amblyopia 
which is characterized by central or cecocentral scotoma.15 
Toxic/nutritional optic neuropathy is quite common in 
  conditions of chronic alcohol abuse and malnutrition 
especially during times of war or famine as was the case in 
Cuba in the early 1990s.16
Materials and methods
Medical case records of all cases of nonglaucomatous optic 
neuropathy seen in the Eye Clinic of University of Port 
Harcourt Teaching Hospital (UPTH) over a 5-year period 
(  January 2006–December 2010) were reviewed. Relevant 
data including age, sex, corrected visual   acuity (Snellen 
chart), and intraocular pressure (Perkins MK 2 Hand held 
applanation tonometer; HS Clemens Clarke International, 
Essex, UK), and fundus findings (  slit-lamp   biomicroscopy 
with +78D) were extracted from the records. Other details 
were their central visual field analysis (Humphrey visual 
field analyzer, Model 740; Carl Zeiss Ophthalmic Systems 
Inc, Dublin, CA) and color vision results (  Ishihara pseudoi-
sochromatic color plates). Exclusion criteria included all 
cases of glaucomatous optic neuropathy (based on abnormal 
central visual field results [Humphrey perimetry], vertical 
cup/disk ratio .0.5, with or without elevated intra-ocular 
pressure). Data was   analyzed using Epi Info (v 6.02; Cen-
ters for Disease Control and   Prevention, Atlanta, GA) and 
P values ,0.05 were   considered significant.
Results
Table 1 shows the age and gender distribution of patients 
who were diagnosed with optic neuropathy during the 
period under review. A total of 99 cases of optic   neuropathy 
Table 1 Age and gender distribution of patients with optic 
neuropathy
Age group  
(years)
Sex
Male (%) Female (%) Total (%)
,10 3 (3.0%) 3 (3.0%)
10–19 9 (9.1%) 6 (6.1%) 15 (15.2%)
20–29 18(18.2%) 10 (10.1%) 28 (28.3%)
30–39 6 (6.1%) 6 (6.1%) 12 (12.1%)
40–49 4 (4.0%) 4 (4.0%) 8 (8.1%)
50–59 5 (5.0%) 10 (10.1%) 15 (15.2%)
60–69 7 (7.1%) 5 (5.1%) 12 (12.1%)
70–79 3 (3.0%) 2 (2.0%) 5 (5.0%)
80–89 1 (1.0%) 1 (1.0%)
Total 52 (52.5%) 47 (47.5%) 99 (100%)
Table 2 Corrected visual acuity of affected eyes
Visual acuity Right eye (%) Left eye (%) Total (%)
6/12 
6/18
6 (3.9%) 
9 (5.8%)
8 (5.2%) 
5 (3.2%)
14 (9.0%) 
14 (9.0%)
6/24 7 (4.5%) 7 (4.5%) 14 (9.0%)
6/36 9 (5.8%) 8 (5.2%) 17 (11.0%)
6/60 12 (7.7%) 16 (10.3%) 28 (18.0%)
CF 10 (6.5%) 12 (7.7%) 22 (14.2%)
hM 
LP
15 (9.7%) 
1 (0.6%)
6 (3.9%) 
3 (1.9%)
21 (13.6%) 
4 (2.6%)
nPL 13 (8.4%) 8 (5.2%) 21 (13.6%)
Total 82 (52.9%) 73 (47.1%) 155 (100%)
Abbreviations: CF, counting fingers; HM, hand movement; LP, light perception; 
nPL, no perception of light.
Table 3 Types of optic neuropathy
Types of optic neuropathy Number (%)
Optic atrophy (most causes unknown) 41 (41.4%)
Optic neuritis 27 (27.3%)
nutritional optic neuropathy/unknown 31 (31.3%)
Total 99 (100)Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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were seen over a 5-year period. There were 52 (52.5%) 
males and 47(47.5%) females giving a male:female ratio 
of 1.1:1. The mean age of those with optic neuropathy was 
40 ± 18.77 years. Over 55% of those with optic neuropathy 
were aged between 10 and 39 years old. Those in the age 
group 20–29 years were the most affected (28.3%) and in 
this particular group, males were about twice as affected as 
females (male:female = 1.8:1). The least affected were those 
in both extremes of ages (,10 years old: 3%; 80–89 year 
olds: 1%).
Table 2 shows the corrected visual acuity of the study 
subjects. The right eye was involved in 82 cases (52.9%) 
and the left eye in 73 cases (47.1%). Twenty-two patients 
(22.2%) had bilateral involvement while 77.8% (N = 77) 
had unilateral involvement. Altogether, 155 eyes of 99 
patients were involved. Over 60% of the patients pre-
sented with visual acuities #6/60, only 14 patients had 
VA $ 6/18.
Table 3 shows the types of optic neuropathy in this study. 
About 40% of the patients had optic atrophy at presentation. 
Optic neuritis (retrobulbar neuritis and papillitis) accounted 
for 27.3% of cases, while the rest (31.3%) were due mainly 
to nutritional causes (on account of temporal disk pallor) and 
some unknown causes. The mean age of those with optic 
atrophy was 41.35 ± 18.28 years and for those with optic 
neuritis 26.67 ± 12.10 years.
Only 65 patients had perimetry. The remaining 34 
did not because of severe optic atrophy. Table 5 shows 
that most patients (40%) had cecocentral scotoma fol-
lowed by generalized depression of sensitivity (15.3%). 
Enlargement of the blindspot and central scotoma were 
noted in five cases each. Of the 20 patients who had pink/
hyperemic disks, fifteen (25.9%) had normal central visual 
field (CVF) results.
Discussion
Optic atrophy was the most common type of nonglaucoma-
tous optic neuropathy reported in this study. This is much 
higher than the study by Gupta et al,8 however, a similarity 
between this study and that by Gupta et al was that most of 
our patients were also in their early forties. In their study, 
only twelve patients were studied and this could account for 
the small number of patients with optic atrophy. In addition, 
patients in our setting tended to report late for treatment 
and this may account for the large number of cases of optic 
atrophy as these patients may be seen at the terminal end of 
the disease process.
Cassava and cassava products are staple foods in south-
ern Nigeria and there is good evidence that it causes optic 
neuropathy because of its high cyanide content.17,18 Could 
this be the case with some of our patients? This could 
also explain the large number of cases of nutritional optic 
neuropathy seen in this study. A characteristic of patients 
in our environment is the tendency to withhold important 
information about their health especially if they think it 
may be blamed for their illness. Despite this, there is the 
likelihood that chronic alcohol consumption and nutritional 
deficiency may play important roles in some of the cases 
of optic neuropathy seen because illicit gin is brewed and 
consumed in large quantities in this environment. Even 
though many cases of optic atrophy were seen, it was dif-
ficult to say for certain what the exact causes were but they 
were certainly not glaucomatous based on the exclusion 
criteria; most looked to be due to secondary causes such as 
resolved disk edema. All cases of optic neuropathy occurred 
in isolation. We did not record any cases of hereditary optic 
neuropathy and there was also no evidence of a compressive 
lesion in any of our cases. It is not entirely certain if some 
of the neuropathies could have been due to ischemic optic 
neuropathy as a few of the fundus pictures revealed slightly 
hyperemic disks.
Table 4 Fundus findings
Fundus picture Number (%)
Pink/hyperemic disk 20 (20.2%)
Temporal disk pallor 31 (31.3%)
Pale neuroretinal rim 41 (41.4%)
Blurred disk margins 7 (7.1%)
Total 99 (100%)
Table 5 Central visual field analysis (Humphrey)
Fundus picture Number Normal  
CVF
Central  
scotoma
Cecocentral  
scotoma
Altitudinal  
defect
Generalized depression  
of sensitivity
Enlargement   
of blind spot
Temporal disk pallor 31 – 5 (7.7%) 26 (40%) – – –
Blurred disk margins 7 – – – – 2 (3.0%) 5 (7.7%)
Pink/hyperemic disk 20 15 (23.1%) – – 4 (6.2%) 1 (1.5%) –
Optic atrophy 7 – – – – 7 (10.8%) –
Total 65 (100%) 15 (23.1%) 5 (7.7%) 26 (40%) 4 (6.2%) 3 (15.3%) 5 (7.7%)
Abbreviation: CVR, control visual field.Clinical Ophthalmology
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One of the major limitations of this study is the fact that 
none of our patients had an Optical Coherence Tomography 
(OCT) to properly assess the retinal nerve fiber layer which 
would have helped in characterizing the different types of 
optic neuropathies. OCT would also have assisted in categori-
cally differentiating glaucomatous from nonglaucomatous 
optic neuropathy.
Conclusion
Nonglaucomatous optic neuropathies resulting in optic 
atrophy are not uncommon in our environment and several 
factors may be implicated but this is difficult to know because 
of the late presentation of most patients. A prospective study 
is proposed in future and should be able to address this issue 
as this may be part of the exclusion criteria.
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